Ulthera is an emerging ultrasound-based medical technology company that is raising the bar for aesthetic medical procedures. While the demand and promise for noninvasive energy-based procedures continue to grow, the ability to consistently deliver safe, significant, and satisfying results has been elusive. Ulthera is a company dedicated to achieving these types of results through elective medical procedures for rejuvenation of the skin and its underlying tissue.
The UltheraÂ® System, with its patented DeepSEEâ„¢ technology, is an engineering triumph that has adapted the imaging and therapy capabilities of time-honored medical ultrasound to address the unmet needs of the aesthetic marketplace. What began as an exploration of image-guided cancer therapy evolved over seven years into the founding of Ulthera, Inc.
Funding Rounds (4) - $39.65MUpdate
Current Team (12)Update
|Apr 27, 2016||Business Wire - Merz Pharma Announces New Investment in Cytrellis Biosystems|
|Apr 12, 2016||Business Wire - Convergence: Life Science and IT Leaders Come Together to Make Life Better for Patients|
|Sep 17, 2015||Business Wire - Research and Markets: Global Implantable Medical Devices Market 2015 Report with - Allergan, Johnson & Johnson, Nobel Biocare, Straumann, and Stryker Dominating|
|Sep 16, 2015||Mass Device - SynCardia sets terms for $28m IPO|
|Sep 3, 2015||Mass Device - GC Aesthetics spikes IPO|
|Aug 3, 2015||Business Wire - Ulthera Announces Two Year FDA Clearance for Cellfina™ System|
|Jul 15, 2015||Business Wire - Merz Pharma Canada Announces the Approval of Radiesse|
|Jun 29, 2015||PRWeb Sitemap - Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures|
2150 S. Country Club Drive
Mesa, AZ 85210